• Profile
Close

A randomized, controlled study evaluating effects of amlodipine addition to chelators to reduce iron loading in patients with thalassemia major

European Journal of Haematology Oct 03, 2017

Eghbali A, et al. - Authors performed this randomized, controlled study to evaluate the effects of amlodipine addition to chelators to reduce iron loading in patients with thalassemia major. In this work, the addition of amlodipine to iron chelators proved beneficial for reduction of iron loading in patients with thalassemia major. This combination therapy appeared safe.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay